USANA Health Sciences, Inc.

NYSE:USNA Stok Raporu

Piyasa değeri: US$693.3m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

USANA Health Sciences Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Jim Brown

İcra Kurulu Başkanı

US$2.5m

Toplam tazminat

CEO maaş yüzdesi28.7%
CEO görev süresi7.9yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi7.7yrs
Yönetim Kurulu ortalama görev süresi6.6yrs

Son yönetim güncellemeleri

Recent updates

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Sep 26
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

Sep 08
Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

Jul 17
There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

May 29
USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 03
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

May 01
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

CEO Tazminat Analizi

Jim Brown'un ücretlendirmesi USANA Health Sciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 29 2024n/an/a

US$55m

Mar 30 2024n/an/a

US$62m

Dec 30 2023US$2mUS$710k

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Tazminat ve Piyasa: Jim 'ın toplam tazminatı ($USD 2.47M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 3.23M ).

Tazminat ve Kazançlar: Jim şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.


CEO

Jim Brown (55 yo)

7.9yrs

Görev süresi

US$2,472,017

Tazminat

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kevin Guest
Executive Chairman7.4yrsUS$3.91m0.064%
$ 443.1k
Jim Brown
CEO & President7.9yrsUS$2.47mVeri yok
G. Hekking
Chief Financial Officer7.4yrsUS$1.47m0%
$ 0
Walter Noot
Chief Operating Officer5yrsUS$1.42mVeri yok
P. Foukas
Chief Legal Officer6.3yrsUS$1.29mVeri yok
Daniel Macuga
Chief Communications & Marketing Officer12.8yrsUS$1.15m0%
$ 0
Myron Wentz
Founder & Chairman Emeritus32.8yrsVeri yok41.28%
$ 286.2m
John Cuomo
Executive Director of Product Development & Technology11.8yrsVeri yokVeri yok
Robert Sinnott
Chief Scientific Officer8.2yrsVeri yokVeri yok
Peter Benedict
Chief Information Officerno dataVeri yokVeri yok
Patrique Richards
Executive Director of Investor Relations & Business Developmentno dataVeri yokVeri yok
Paul Jones
Chief People Officer3.7yrsUS$637.78k0%
$ 0

7.7yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: USNA 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kevin Guest
Executive Chairman7.4yrsUS$3.91m0.064%
$ 443.1k
Myron Wentz
Founder & Chairman Emeritus4.4yrsVeri yok41.28%
$ 286.2m
Gilbert Fuller
Lead Independent Director16.1yrsUS$251.60k0%
$ 0
Peggie Pelosi
Independent Director5.8yrsUS$231.40k0.019%
$ 132.3k
Timothy Wood
Independent Director5yrsUS$218.40k0.031%
$ 215.6k
Christine Wood
Member of Scientific Advisory Councilno dataVeri yokVeri yok
Monica Lewis
Member of Scientific Advisory Councilno dataVeri yokVeri yok
Peter Rugg
Chairperson of Scientific Advisory Council20.8yrsVeri yokVeri yok
Bart Moore
Member of Scientific Advisory Councilno dataVeri yokVeri yok
Heather Tick
Member of Scientific Advisory Councilno dataVeri yokVeri yok
Frederic Winssinger
Independent Director8.4yrsUS$233.60k0.020%
$ 140.0k
J. Nixon
Independent Director2.3yrsUS$218.40k0.019%
$ 129.6k

6.6yrs

Ortalama Görev Süresi

68yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: USNA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.6 yıldır).